First new treatment approved for Alzheimer’s disease in over a decade More: Biogen, Eisai’s Alzheimer’s drug aducanumab makes history with US approval Source: News
read moreBiogen’s ‘shockingly broad’ Aduhelm label—and $56K price—set up a $10B launch, analysts say nhigginsdunn Mon, 06/07/2021 – 14:08 More: Biogen's 'shockingly broad' Aduhelm label—and K price—set up a B launch, analysts say Source: fierce
read moreASCO: AstraZeneca details Calquence’s heart safety edge over Imbruvica as both brace for BeiGene’s rival Brukinsa aliu Mon, 06/07/2021 – 11:40 More: ASCO: AstraZeneca details Calquence's heart safety edge over Imbruvica as both brace for BeiGene's rival Brukinsa Source: fierce
read moreRoche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey bbulik Mon, 06/07/2021 – 11:14 More: Roche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey Source: fierce
read moreMerck investigating noose at NC vaccine plant as execs pledge swift response kdunleavy Mon, 06/07/2021 – 10:12 More: Merck investigating noose at NC vaccine plant as execs pledge swift response Source: fierce
read moreAstraZeneca takes PARP battle to court, seeking a larger claim to GSK’s key cancer med Zejula: report aliu Mon, 06/07/2021 – 09:45 More: AstraZeneca takes PARP battle to court, seeking a larger claim to GSK's key cancer med Zejula: report
read more© 1994 - 2026 B.M. Pharmaceuticals